Lixte Biotechnology (LIXTW) has had the highest return since July 1, 2025 by a nano-cap US stock, returning 597.4%.
| ASSET | % RETURN |
|---|---|
Lixte Biotechnology (LIXTW) | 597.42% |
Sonnet Biotherapeutics (SONN) | 218.7% |
Global Interactive Technologies (GITS) | 182.35% |
BP Prudhoe Bay Royalty Trust (BPT) | 175% |
Lixte Biotechnology (LIXT) | 174.76% |
Windtree Therapeutics (WINT) | 82.2% |
Earlyworks Co, Ltd American Depositary Shares (ELWS) | 80.79% |
Pineapple Financial (PAPL) | 58.5% |
MoneyHero Limited Class A Ordinary Shares (MNY) | 50.49% |
Golden Heaven Group Holdings Ltd Ordinary Shares (GDHG) | 45.39% |
Powell Max Limited Class A Ordinary Shares (PMAX) | 41.57% |
Inspira Technologies Oxy BHN (IINN) | 40% |
Scienture (SCNX) | 39.42% |
Citius Pharmaceuticals (CTXR) | 36.42% |
Jowell Global (JWEL) | 35% |
MicroAlgo (MLGO) | 34.52% |
Workhorse (WKHS) | 34.26% |
LMF Acquisition Opportunities (ICU) | 34.17% |
ESS Tech (GWH) | 32.82% |
China Liberal Education (CLEU) | 32.5% |
Offerpad Solutions (OPAD) | 31.58% |
Oblong (OBLG) | 30.7% |
Data Storage (DTSTW) | 30.5% |
Cognition Therapeutics (CGTX) | 29.56% |
Abits (ABTS) | 28.42% |
Nano-cap stocks are treated as having a market cap of <= $50M.
